Home
 /
Papers
 /
Biochemistry
 /
Computational design of cysteine proteases
Preprint
Open access
V1
Top 1% · Validated by QED

Computational design of cysteine proteases

Hojae Choi, Brian Coventry, Magnus Bauer +15 more
November 2025
 ·
bioRxiv
 ·
DOI 
10.1101/2025.11.21.689808
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Biochemistry this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

Overturning the assumption that computational enzyme design cannot tackle high-barrier reactions, this work delivers the first de novo cysteine proteases—with novel folds and 30-million-fold rate enhancement—unlocking programmable peptide-bond cleavage for medicine and biotechnology.

QED claims analysis

Summary

Deep learning-guided de novo design using RFDiffusion2-MI generates functional cysteine proteases with novel folds (TM-score < 0.50) that achieve rate enhancements up to 3 × 10⁷-fold over uncatalyzed peptide bond hydrolysis through computationally specified catalytic triads and substrate binding sites, with crystal structures confirming atomic-level accuracy (Cα RMSD < 1.2 Å) of the design methodology.

See full analysis
Main Claim 1 –

RFDiffusion2-MI Generates De Novo Cysteine Proteases with Binding Sites

Main Claim 2 –

Designed Cysteine Proteases Show 19% Functional Cleavage Success

Supporting evidence

  • Protease Activity Requires Cys–His Triad; Oxyanion Hole Variable
Main Claim 3 –

Designed Cysteine Proteases Achieve Up to 3×10^7 Rate Enhancement

Supporting evidence

  • Optimized Designs Show Michaelis–Menten Kinetics and 0.24–12 M−1s−1
  • ProteinMPNN Redesign Boosts Protease Activity 1.2- to 31-Fold
  • Designed Proteases Show Natural-Like pH Profile with pH 7 Optimum
  • Designed Proteases Are Thermostable, Active to 70°C, Tm >80°C
  • Designed Proteases Show Substrate Selectivity and TTN Above 19
Main Claim 4 –

Crystal Structures Confirm Atomic-Accuracy Agreement with Design Models

Supporting evidence

  • Designed Proteases Adopt Novel Folds Distinct from Natural Proteases

Abstract

Despite advances in de novo enzyme design, success has been largely limited to low energy barrier model reactions. Amide bonds such as those linking amino acids along the peptide backbone are stable for hundreds of years in neutral aqueous solution because of the high energy barrier to hydrolysis. Here we describe the use of a new deep learning method, RFD2-MI, to de novo design enzymes which utilize an activated cysteine nucleophile to hydrolyze the polypeptide backbone in a sequence-dependent manner, achieving rate enhancements over the background reaction (kcat/kuncat) of up to 3 × 107. The generated designs have folds very different from the proteases in nature (TM score < 0.50), and crystal structures are very close to the design models (Cα RMSDs < 1.2 Å), highlighting the accuracy of the design methodology. Our approach has broad utility for advancing the design of novel proteases for both biotechnical and medical applications.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?